Cyrille Hulin

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Multiple Myeloma

Clinical Practice

Top Venues

Blood cancer journal

JMIR research protocols

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Cyrille Hulin, Nadia Quignot, Heng Jiang, Hakima Mechiche, Gaëlle Désaméricq
Carfilzomib use in patients with relapsed/refractory multiple myeloma in France: A national retrospective cohort study. EJHaem 5 (4) (2024)
Aurore Perrot, Murielle Roussel, Valerie Lauwers-Cances, Cyrille Hulin, Xavier Leleu, Cyrille Touzeau, Thierry Facon, Clara Mariette, Jean-Marc Schiano, Julie Gay, Lydiane Mordier, Dana Ranta, Amandine Huguet, Soraya Wuillème, Thomas Dejoie, Laure Devlamynck, Jill Corre, Hervé Avet-Loiseau, Phillipe Moreau, Michel Attal
Twice-weekly induction with ixazomib-lenalidomide-dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant-eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014-03. British journal of haematology (2024)
Cyrille Hulin, Nadia Quignot, Heng Jiang, Hakima Mechiche, Gaëlle Désaméricq
Carfilzomib use in patients with relapsed/refractory multiple myeloma in France: A national retrospective cohort study. EJHaem 5 (4) (2024)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Cyrille Hulin, Meral Beksac, Hugh J Goodman, Ivan Spicka, Adrian Alegre, Miles Prince, Frank Campana, Greg Finn, Solenn Le-Guennec, Sandrine Macé, Stéphane Muccio, Alexandra Tavernier, Marie-Claude Rouchon, Paul Gerard Richardson
Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma. Blood cancer journal 11 (10) (2021)
Schjesvold Fredrik, Sara Bringhen, Paul Gerard Richardson, Aurore Perrot, Xavier Leleu, Phillipe Moreau, Meletios- Athanasios Dimopoulos, Cyrille Hulin, Christina Tekle, Meredith C Foster, Elizabeth M Poole, Helgi van de Velde, Thierry Facon
Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis. American journal of hematology 96 (11) (2021)
Charles Mesguich, Cyrille Hulin, Valerie Latrabe, Julien Asselineau, Laurence Bordenave, Paul Perez, Elif Hindié, Gerald Marit
Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial. JMIR research protocols 9 (9) (2020)
Cyrille Hulin, Javier de la Rubia, Meletios A Dimopoulos, Evangelos Terpos, Eirini Katodritou, Vania Tietsche de Moraes Hungria, Hadewijch De Samblanx, Anne-Marie Stoppa, Jesper Aagesen, Deniz Sargin, Anastasia Sioni, Andrew Belch, Joris Diels, Robert A Olie, Don Robinson, Anna Potamianou, Helgi van de Velde, Michel Delforge
Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice. Health science reports 2 (1) (2018)